Saama

Saama provides industry-leading AI-powered analytics platforms that accelerate clinical trial design, execution, and regulatory submission. Its LSAC platform has been used in over 1500 studies by more than 50 biotech companies—including many top global pharmaceutical firms—to reduce time to database lock and improve data quality. The company’s solutions have demonstrated significant reductions in manual work hours and cycle times for key trial processes.

No direct clinical results since the company does not sponsor its own drug programs.

Key metrics include:

• Up to 35% reduction in time to data discovery with Data Hub,
• Over 20,000 hours saved with Smart Data Quality,
• Up to 40% faster patient data review,
• Up to 30% reduction in content drafting time with their document generator.

Their technology has enabled sponsors/CROs to file NDAs more quickly and bring therapies—especially for rare diseases—to market faster.